A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome

A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease usually presenting after infection. Emerging evidence supports that energy metabolism is affected in ME/CFS, but a unifying metabolic phenotype has not been firmly established. We performed global metabolomics, lip...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Fredrik Hoel, August Hoel, Ina K.N. Pettersen, Ingrid G. Rekeland, Kristin Risa, Kine Alme, Kari Sørland, Alexander Fosså, Katarina Lien, Ingrid Herder, Hanne L. Thürmer, Merete E. Gotaas, Christoph Schäfer, Rolf K. Berge, Kristian Sommerfelt, Hans-Peter Marti, Olav Dahl, Olav Mella, Øystein Fluge, Karl J. Tronstad
Natura:	Articolo
Lingua:	English
Pubblicazione:	American Society for Clinical investigation 2021-08-01
Serie:	JCI Insight
Soggetti:	Immunology Metabolism
Accesso online:	https://doi.org/10.1172/jci.insight.149217

Documenti analoghi

Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients.
di: Ingrid G Rekeland, et al.
Pubblicazione: (2022-01-01)

Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients
di: Ingrid G. Rekeland, et al.
Pubblicazione: (2022-01-01)

Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
di: Ingrid G Rekeland, et al.
Pubblicazione: (2024-01-01)

Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome–Results From Open-Label Cyclophosphamide Intervention Study
di: Kari Sørland, et al.
Pubblicazione: (2021-03-01)

B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.
di: Øystein Fluge, et al.
Pubblicazione: (2015-01-01)

Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.
di: Sigrid Lunde, et al.
Pubblicazione: (2016-01-01)

No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
di: Marthe Ueland, et al.
Pubblicazione: (2022-07-01)

Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
di: Mella Olav, et al.
Pubblicazione: (2009-07-01)

Medical School Education on Myalgic Encephalomyelitis
di: Nina Muirhead, et al.
Pubblicazione: (2021-05-01)

Myalgic encephalomyelitis - enigma at the medicine’s crossroads
di: Pavlović Dragan M., et al.
Pubblicazione: (2021-01-01)

Myalgic Encephalomyelitis (ME) or What? An Operational Definition
di: Frank Twisk
Pubblicazione: (2018-09-01)

Myalgic Encephalomyelitis or What? The International Consensus Criteria
di: Frank Twisk
Pubblicazione: (2018-12-01)

The viral origin of myalgic encephalomyelitis/chronic fatigue syndrome.
di: Maureen R Hanson
Pubblicazione: (2023-08-01)

‘The Lightning Process’ and chronic fatigue syndrome/myalgic encephalomyelitis
di: Rosamund Vallings
Pubblicazione: (2022-01-01)

Restricted Spatial Windows of Visibility in Myalgic Encephalomyelitis (ME)
di: Nadia S. Ahmed, et al.
Pubblicazione: (2018-01-01)

Visual Aspects of Reading Performance in Myalgic Encephalomyelitis (ME)
di: Rachel L. Wilson, et al.
Pubblicazione: (2018-08-01)

Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study.
di: Øystein Fluge, et al.
Pubblicazione: (2011-01-01)

Missing the meaning and provoking resistance; a case of myalgic encephalomyelitis.
di: Butler, C, et al.
Pubblicazione: (1996)

Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome
di: Nadja Scherbakov, et al.
Pubblicazione: (2020-06-01)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!
di: Maria Eugenia Ariza
Pubblicazione: (2021-01-01)

Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome
di: Alexandra H. Mandarano, et al.
Pubblicazione: (2018-01-01)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Neurological Entity?
di: Iñigo Murga Gandasegui, et al.
Pubblicazione: (2021-09-01)

Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome
di: Sabine Gravelsina, et al.
Pubblicazione: (2022-10-01)

Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
di: Daniel Missailidis, et al.
Pubblicazione: (2019-07-01)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review
di: Mateo Cortes Rivera, et al.
Pubblicazione: (2019-08-01)

Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
di: Lily Chu, et al.
Pubblicazione: (2019-02-01)

Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
di: Anthony L. Komaroff, et al.
Pubblicazione: (2021-01-01)

An Audit of UK Hospital Doctors’ Knowledge and Experience of Myalgic Encephalomyelitis
di: Keng Ngee Hng, et al.
Pubblicazione: (2021-08-01)

Evaluation of four clinical laboratory parameters for the diagnosis of myalgic encephalomyelitis
di: Kenny L. De Meirleir, et al.
Pubblicazione: (2018-11-01)

Evidence-based care for people with chronic fatigue syndrome and myalgic encephalomyelitis
di: Sharpe, M, et al.
Pubblicazione: (2021)

Evidence-based care for people with chronic fatigue syndrome and myalgic encephalomyelitis
di: White, PD, et al.
Pubblicazione: (2022)

Association between chronic fatigue syndrome/myalgic encephalomyelitis and cardiovascular disease
di: Mawulorm K. I. Denu, et al.
Pubblicazione: (2025-01-01)

Tetrahydrobiopterin in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Friend or Foe?
di: A. F. M. Towheedur Rahman, et al.
Pubblicazione: (2025-01-01)

Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
di: D. Peterson, et al.
Pubblicazione: (2015-01-01)

Development of an expert system for the classification of myalgic encephalomyelitis/chronic fatigue syndrome
di: Fatma Hilal Yagin, et al.
Pubblicazione: (2024-03-01)

Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome
di: Brian Walitt, et al.
Pubblicazione: (2024-02-01)

Comparison of T-cell receptor diversity of people with myalgic encephalomyelitis versus controls
di: Joshua J Dibble, et al.
Pubblicazione: (2024-01-01)

Angina Simultaneously Diagnosed with the Recurrence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
di: Koki Li, et al.
Pubblicazione: (2021-03-01)

Factors Influencing the Prognosis of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
di: Alaa Ghali, et al.
Pubblicazione: (2022-10-01)

Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
di: Santiago Herrera, et al.
Pubblicazione: (2018-12-01)